# Tadalafil in Subjects With Mild to Moderate Hypertension

> **NCT00157326** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 180 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** tadalafil

## Key facts

- **NCT ID:** NCT00157326
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2007-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157326, "Tadalafil in Subjects With Mild to Moderate Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00157326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*